Pharmacovigilance in Australia
Bulpitt, C.J.
Medical Journal of Australia 156(6): 375-376
1992
ISSN/ISBN: 0025-729X PMID: 1545742 Accession: 040962811
Article/Abstract emailed within 1 workday
Payments are secure & encrypted
References
Blayac, J.P.; Haramburu, F.; Lerebours, S.; Vial, T. 2000: Information du prescripteur et aide à la prescription : rôle des centres régionaux de pharmacovigilance : Pharmacovigilance - Drug information and prescription guidance : missions of the French regional pharmacovigilance centers : Pharmacovigilance la Presse Medicale (1983) 29(2): 115-118Laroche, M-Laure; Batz, A; Géniaux, Hélène; Féchant, C; Merle, L; Maison, P 2016: La pharmacovigilance europenne : place du Comit pour lvaluation des risques en matire de pharmacovigilance (Pharmacovigilance Risk Assessment Committee PRAC) dans lorganisation et le processus dcisionnel Thérapie 71(2): 151-160
Dhanani, A.; Castot, A. 2000: La pharmacovigilance européenne : aspects réglementaires : Pharmacovigilance - The european pharmacovigilance : regulatory aspects : Pharmacovigilance la Presse Medicale (1983) 29(2): 107-110
Welsch, M.; Alt, M.; Richard, M.H.; Imbs, J.L. 2000: Le réseau de pharmacovigilance français : structure et missions : Pharmacovigilance - The French pharmacovigilance system : structure and missions : Pharmacovigilance la Presse Medicale (1983) 29(2): 102-106
Pillans, P.I.; Mathew, T.H.; Coulter, D.M. 1999: Pharmacovigilance in Australia and new Zealand: towards 2000 Medical Journal of Australia 170(6): 245-246
Ruellan, A.L.; Bellissant, E.; Riche, C.; Grude, F.; Bourgeois, H.; Carlhantkowaski, D.; Douillard, J.Y.; Jamet, A.; Jolliet, P.; Lainecessac, P.; Metges, J.P.; Polardriou, E. 2013: Collaboration entre l'Observatoire dédié au cancer et les Centres régionaux de pharmacovigilance: premiers résultats sur la pharmacovigilance: des médicaments anticancéreux - Observatory dedicated to cancer and CRPV collaboration: first results in pharmacovigilance of innovative cancer drugs la Lettre du Pharmacologue (Boulogne) 27(2): 51-57
Clothier, H.J.; Crawford, N.W.; Russell, M.; Kelly, H.; Buttery, J.P. 2017: Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia Drug Safety 40(6): 483-495
Lavarenne, J. 1991: Pharmacovigilance of hypolipidemic drugs a retrospective study of the data of the french system of pharmacovigilance Therapie (London/Paris) 46(5): 345-346
Llau, M.E.; Damase-Michel, C.; Lapeyre-Mestre, M.; Vie, M.; Rascol, O. 1994: Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992 Therapie 49(2): 123-127
Bussieres, J.F.; Blond, M.; Lebel, D.; Martin, B. 2006: Intégration de la pharmacovigilance à la pratique clinique - Integrating pharmacovigilance to clinical pharmacy practice Journal de Pharmacie Clinique (Paris) 25(2): 93-100
A, 1995: Bonnes pratiques de pharmacovigilance : médicaments à usage humain - Good practices in pharmacovigilance French Society of Clinical Pharmacology and Therapeutics. Meeting (Montpellier 1995-04) 50(6): 547-555
Van Ganse, E. 1995: Utilisation de bases de données en pharmacovigilance : deux exemples - Use of databases in pharmacovigilance two examples French Pharmacovigilance Conference 50(5): 409-412
2008: Écouter les patients enrichit la pharmacovigilance - Listening to patiens for improve pharmacovigilance la Revue Prescrire 28(297): 506-507
Borg, J-Joseph.; Aislaitner, G.; Pirozynski, M.; Mifsud, S. 2011: Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance Drug Safety 34(3): 187-197
Garashi, H.Y.; Steinke, D.T.; Schafheutle, E.I. 2022: A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators Therapeutic Innovation and Regulatory Science 56(5): 717-743
Castot, A.; Djezzar, S.; Deleau, N.; Guillot, B.; Efthymiou, M.L. 1997: Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants Therapie 52(2): 97-103
Gerland, C.; Delattre, D.; Dutel, C. 1995: Pharmacovigilance européenne : based règlementaires - European pharmacovigilance : main rules Lyon Pharmaceutique 46(3): 167-172
Wang, J.; Zhang, M.; Li, S.; He, B. 2018: Adapting and applying common methods used in pharmacovigilance to the environment: a possible starting point for the implementation of eco-pharmacovigilance Environmental Toxicology and Pharmacology 61: 67-70
Bencheikh, P.R. 2001: Pharmacovigilance, modèle pour le développement de la sécurité sanitaire - Pharmacovigilance and development of the sanitary safety Esperance Medicale 8(77): 548-550
Jha, N.; Rathore, D.S.; Shankar, P.R.; Bhandary, S.; Alshakka, M.; Gyawali, S. 2017: Knowledge, Attitude and Practice Regarding Pharmacovigilance and Consumer Pharmacovigilance among Consumers at Lalitpur District, Nepal Journal of Nepal Health Research Council 15(1): 31-37